As AI continues to advance, its future looks promising yet challenging. On one hand, AI holds the potential to solve some of humanity's most pressing problems, such as climate change, by optimizing energy consumption and predicting environmental changes. On the other hand, there are ethical and societal implications to consider, including privacy concerns, bias in AI algorithms, and the digital divide.
With the Phase 1b data currently being finalized (full results expected by the end of 2025), Herantis Pharma is already prepping for Phase 2 trials . This next stage will be the first to truly measure the